Downstream signaling pathways initiated by S1PR2 also play a role in multiple sclerosis, fibrosis, and inflammation.67 Our protein docking analyses revealed that fingolimod’s binding mode to S1PR2 is highly homologous to that of S1P. The gene discussed is MBTPS1; the disease is multiple sclerosis.